Engblom Camilla, Pfirschke Christina, Zilionis Rapolas, Da Silva Martins Janaina, Bos Stijn A, Courties Gabriel, Rickelt Steffen, Severe Nicolas, Baryawno Ninib, Faget Julien, Savova Virginia, Zemmour David, Kline Jaclyn, Siwicki Marie, Garris Christopher, Pucci Ferdinando, Liao Hsin-Wei, Lin Yi-Jang, Newton Andita, Yaghi Omar K, Iwamoto Yoshiko, Tricot Benoit, Wojtkiewicz Gregory R, Nahrendorf Matthias, Cortez-Retamozo Virna, Meylan Etienne, Hynes Richard O, Demay Marie, Klein Allon, Bredella Miriam A, Scadden David T, Weissleder Ralph, Pittet Mikael J
Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA 02114, USA.
Graduate Program in Immunology, Harvard Medical School, Boston, MA 02115, USA.
Science. 2017 Dec 1;358(6367). doi: 10.1126/science.aal5081.
Bone marrow-derived myeloid cells can accumulate within tumors and foster cancer outgrowth. Local immune-neoplastic interactions have been intensively investigated, but the contribution of the systemic host environment to tumor growth remains poorly understood. Here, we show in mice and cancer patients ( = 70) that lung adenocarcinomas increase bone stromal activity in the absence of bone metastasis. Animal studies reveal that the cancer-induced bone phenotype involves bone-resident osteocalcin-expressing (Ocn) osteoblastic cells. These cells promote cancer by remotely supplying a distinct subset of tumor-infiltrating SiglecF neutrophils, which exhibit cancer-promoting properties. Experimentally reducing Ocn cell numbers suppresses the neutrophil response and lung tumor outgrowth. These observations posit osteoblasts as remote regulators of lung cancer and identify SiglecF neutrophils as myeloid cell effectors of the osteoblast-driven protumoral response.
骨髓来源的髓样细胞可在肿瘤内积聚并促进癌症生长。局部免疫与肿瘤的相互作用已得到深入研究,但全身宿主环境对肿瘤生长的作用仍知之甚少。在此,我们在小鼠和癌症患者(n = 70)中发现,肺腺癌在无骨转移的情况下会增加骨基质活性。动物研究表明,癌症诱导的骨表型涉及表达骨钙素(Ocn)的骨成骨细胞。这些细胞通过远程供应具有促癌特性的肿瘤浸润性SiglecF中性粒细胞的一个独特亚群来促进癌症。实验性减少Ocn细胞数量可抑制中性粒细胞反应和肺肿瘤生长。这些观察结果将成骨细胞定位为肺癌的远程调节因子,并将SiglecF中性粒细胞确定为成骨细胞驱动的促肿瘤反应的髓样细胞效应器。